Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function

Completed

Conditions studied: Congenital Disorders

In brief

The purpose of this chart review study is to examine the effects of beta -adrenergic blocking agents on systemic ventricular dimensions, systemic atrioventricular valve function and exercise tolerance in patients with transposition of the great arteries (TGA) and systemic ventricular dysfunction.

Key facts

Study ID

NCT00313352

Run by

Emory University

People needed

110

Starts

1997-01-01

Expected to finish

2007-03-01

Last updated by the study team

2013-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients followed-up at Emory University Hospital and The Emory Clinic who meet the following inclusion criteria:
• Age ≥ 18 years
• Diagnosis: Complete d-TGA or Congenitally Corrected TGA with a systemic morphologic right ventricle
• Patients > 18 years of age seen at The Emory Clinic and Emory University Hospital with transposition of the great arteries
• Systemic ventricular ejection fraction < 50% with or without a clinical diagnosis of heart failure
• Echocardiogram performed between January 1, 1997and February 1, 2006

You may not qualify if…

• Those who do not meet inclusion criteria.

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.